ENDRA Life Sciences Inc (NDRA)

NASDAQ

$4.95

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.

Sector:

Industry:

68 analysts

Buy

Target: $25 (+405.56%)

Market Cap

$6.96M

Free Cash Flow Yield

-71.96%

Adjust inflation

Log

Valuation

Market Cap$6.96M

P/S1838.78

P/B3.87

Profitability

EBITDA-$6.43M

EPS-$7.41

Financial Health

Free Cash Flow Yield-71.96%

Growth & Risk

EPS 5Y CAGR-69.42%

FCF 5Y CAGR-13.97%

Sharpe Ratio0.12